- Home
- EPIX vs RECT Comparison
EPIX vs RECT Comparison
Compare EPIX & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- RECT
- Stock Information
- Founded
- EPIX 2009
- RECT 1997
- Country
- EPIX Canada
- RECT Singapore
- Employees
- EPIX N/A
- RECT N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- RECT
- Sector
- EPIX Health Care
- RECT
- Exchange
- EPIX Nasdaq
- RECT Nasdaq
- Market Cap
- EPIX 65.3M
- RECT N/A
- IPO Year
- EPIX N/A
- RECT 2024
- Fundamental
- Price
- EPIX $1.71
- RECT $4.71
- Analyst Decision
- EPIX Hold
- RECT
- Analyst Count
- EPIX 3
- RECT 0
- Target Price
- EPIX $2.00
- RECT N/A
- AVG Volume (30 Days)
- EPIX 276.9K
- RECT 21.3K
- Earning Date
- EPIX 05-08-2025
- RECT 03-27-2025
- Dividend Yield
- EPIX N/A
- RECT N/A
- EPS Growth
- EPIX N/A
- RECT N/A
- EPS
- EPIX N/A
- RECT 0.14
- Revenue
- EPIX N/A
- RECT $33,502,767.00
- Revenue This Year
- EPIX N/A
- RECT N/A
- Revenue Next Year
- EPIX N/A
- RECT N/A
- P/E Ratio
- EPIX N/A
- RECT $32.63
- Revenue Growth
- EPIX N/A
- RECT 8.42
- 52 Week Low
- EPIX $1.40
- RECT $2.70
- 52 Week High
- EPIX $7.88
- RECT $7.68
- Technical
- Relative Strength Index (RSI)
- EPIX 51.16
- RECT N/A
- Support Level
- EPIX $1.74
- RECT N/A
- Resistance Level
- EPIX $1.85
- RECT N/A
- Average True Range (ATR)
- EPIX 0.08
- RECT 0.00
- MACD
- EPIX -0.01
- RECT 0.00
- Stochastic Oscillator
- EPIX 13.33
- RECT 0.00
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.